Search Results

This multidisciplinary discussion seeks to develop a standardized framework that allows community oncologists to easily assess patients for CAR T-cell therapy, with a focus on large B cell lymphoma.

The successful deployment of technology in cancer practices, promises to improve the quality of patient care and the patient experience, while also alleviating excessive burdens on clinicians and staff.

As precision medicine becomes more common in the management of lung cancer, little is understood about the patient experience with biomarker testing, particularly of underserved patients. This study used survey and focus group methodology to determine patient perspectives on the educational needs within this community.